. Author manuscript; available in PMC: 2014 Apr 1.

Published in final edited form as: Am J Obstet Gynecol. 2013 Apr;208(4):316.e1–316.e6. doi: 10.1016/j.ajog.2013.01.024

Table 1.

Maternal Baseline Characteristics among participants included in secondary analysis (n=117)

	Treatment Arm			p-value
	EPA-Rich Fish Oil (n=40)	DHA-Rich Fish Oil (n=37)	Placebo (n=40)	p-value
Age, years	30.0 ± 4.9	30.2 ± 4.7	30.7 ± 5.8	NS
Gestational age at enrollment, weeks	16.1 ± 2.6	16.8 ± 2.3	16.2 ± 2.4	NS
Gravidity	2.4 ± 1.3	2.5 ± 1.2	2.6 ± 2.06	NS
Race/ethnicity				NS
White	33 (82.5)	28 (75.7)	34 (85.0)
African-American	4 (10.0)	5 (13.5)	1 (2.5)
Hispanic/Latina	1 (2.5)	3 (8.1)	2 (5.0)
Asian	1 (3)	1 (3)	1 (2)
American Indian or Alaska Native	0 (0)	0 (0)	1 (2)
Native Hawaiian or other Pacific Islander	1 (2.5)	0 (0)	0 (0)
History of allergy (self-reported)	8 21)	9 (24)	9 (22)	NS

Data are expressed as mean ± standard deviation or frequency (%).

SD = standard deviation, NS= not significant.